At Reuters Pharma USA in Philadelphia, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US ...

The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing ...

Cell and gene therapies offers transformative benefits to patients, including revolutionary treatment potential for cancer, ...

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and ...

Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...

Lilly said it is planning to request a re-examination of the CHMP's appraisal of Kisunla, pointing out that the drug has ...

Dr Marks formally resigned from his post on 28th March and is due to step down on 5th April, and his resignation letter ...

Celebrating its 10th anniversary, the Microbiome Movement USA Summit will reunite the community with perspectives from 140+ ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein (a) levels by more than 90% for at least six ...

But, of course, young people themselves need to be offered a place at the table to make the changes they need for their own ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...